Access to innovative medications for people with kidney failure; reimbursement; drug pricing; most favored nation drug pricing; Medicare kidney care access and payment issues.
Source-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 15, 2026
- Income
- Not reported
- Expenses
- $500,000.00
- Registrant
- ARDELYX, INC.
- Client
- ARDELYX, INC.
- Filing UUID
- 56915384-5a1c-421b-841f-e4a4456872f1
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.